Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Disease-2019 (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04390217
What this trial is testing

LB1148 for Pulmonary Dysfunction Associated With COVID-19 Pneumonia

Who this might be right for
COVID-19Coronavirus Disease 2019Covid19+1 more
Leading BioSciences, Inc
Early research (Phase 1)Study completedNCT05525910
What this trial is testing

Relative Bioavailability Study of Nirmatrelvir/Ritonavir 4 Different Fixed Dose Combination Tablets Relative to the Commercial Tablets in Healthy Participants

Who this might be right for
Biological AvailabilityHealthy Participants
Pfizer 15
Early research (Phase 1)Study completedNCT04644120
What this trial is testing

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
CoronaVirus Disease-2019 (COVID-19)
AbbVie 25
Not applicableUnknownNCT04659135
What this trial is testing

ASCO Survey on COVID-19 in Oncology (ASCO) Registry

Who this might be right for
NeoplasmsCoronavirus
American Society of Clinical Oncology 7,000
Post-approval studies (Phase 4)Study completedNCT04394117
What this trial is testing

Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY Disease

Who this might be right for
Coronavirus Disease 2019COVID-19
The George Institute 787
Not applicableStudy completedNCT04389944
What this trial is testing

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Who this might be right for
Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)
University Hospital, Basel, Switzerland 15
Not applicableStudy completedNCT04314817
What this trial is testing

Adverse Events Related to Treatments Used Against Coronavirus Disease 2019

Who this might be right for
CoronavirusIatrogenic DiseaseAcute Kidney Injury+1 more
Groupe Hospitalier Pitie-Salpetriere 1,000
Not applicableStudy completedNCT04828772
What this trial is testing

Anticoagulation Treatment Patterns and Outcomes of Participants Hospitalized With Coronavirus Disease 2019 (COVID-19) in Japan

Who this might be right for
COVID-19
Bristol-Myers Squibb 9,282
Testing effectiveness (Phase 2)Study completedNCT04547127
What this trial is testing

Evaluate Safety and Efficacy of Convalescent Methylene Blue Treated (MBT) Plasma From Donors Recovered From Coronavirus Disease 2019 (COVID-19)

Who this might be right for
COVID-19
Instituto Grifols, S.A. 200
Large-scale testing (Phase 3)Ended earlyNCT04508023
What this trial is testing

Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Janssen Research & Development, LLC 1,284
Very early researchEnded earlyNCT04449965
What this trial is testing

Povidone-Iodine Rinses in the Management of COVID-19

Who this might be right for
Covid19
St. Paul's Hospital, Canada 5
Not applicableStudy completedNCT06735300
What this trial is testing

Saliva PCR in Pregnant Women with COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19) Pneumonia
National Cheng-Kung University Hospital 37
Testing effectiveness (Phase 2)Ended earlyNCT04504032
What this trial is testing

A Trial to Evaluate Safety and Efficacy of Rivaroxaban (COVID-19)

Who this might be right for
COVID-19
Gates Medical Research Institute 497
Early research (Phase 1)Study completedNCT05339334
What this trial is testing

Learn About the Study Medicine PF-07321332 and Ritonavir in Adult Healthy Chinese Participants.

Who this might be right for
Healthy Participants
Pfizer 14
Not applicableNo Longer AvailableNCT04597242
What this trial is testing

Expanded Access Study of Exebacase in COVID-19 Patients With Persistent MRSA Bacteremia

Who this might be right for
MRSA Bloodstream InfectionMRSA BacteremiaMRSA Right-sided Endocarditis+1 more
ContraFect
Not applicableUnknownNCT04594460
What this trial is testing

Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19Hydrogen-oxygen GasAMS-H-03
Guangzhou Institute of Respiratory Disease 198
Not applicableStudy completedNCT04739345
What this trial is testing

Effect of Pentoxifylline on Prognosis of Coronavirus Disease 2019 (COVID- 19) Infection

Who this might be right for
Covid19Corona Virus InfectionCytokine Storm
Ain Shams University 69
Not applicableUnknownNCT04352764
What this trial is testing

ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings

Who this might be right for
Covid19
Texas Cardiac Arrhythmia Research Foundation 5,000
Not applicableWithdrawnNCT06163677
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer
Large-scale testing (Phase 3)Ended earlyNCT04889040
What this trial is testing

Study to Evaluate the Effects of RO7496998 (AT-527) in Non-Hospitalized Adult and Adolescent Participants With Mild or Moderate COVID-19

Who this might be right for
COVID-19
Hoffmann-La Roche 216
Next Page